Bo-Ying Bao, Ph.D.
Affiliations: | 2006 | University of Rochester, Rochester, NY |
Area:
Oncology, NutritionGoogle:
"Bo-Ying Bao"Parents
Sign in to add mentor| Yi-Fen Lee | grad student | 2006 | Rochester | |
| (Anti-cancer activity of vitamin D in prostate cancer.) | ||||
BETA: Related publications
See more...
Publications
|
You can help our author matching system! If you notice any publications incorrectly attributed to this author, please sign in and mark matches as correct or incorrect. |
| Tsai YC, Huang SP, Cheng WC, et al. (2024) Identifying the role of MTHFD1L in prostate cancer progression from genetic analysis and experimental validation. American Journal of Cancer Research. 14: 169-181 |
| Chen JY, Chang CF, Huang SP, et al. (2024) Integrated analysis identifies GABRB3 as a biomarker in prostate cancer. Bmc Medical Genomics. 17: 41 |
| Wu HE, Su CC, Wang SC, et al. (2023) Anticancer Effects of Morusin in Prostate Cancer via Inhibition of Akt/mTOR Signaling Pathway. The American Journal of Chinese Medicine. 1-21 |
| Li CY, Huang SP, Chen YT, et al. (2022) TNFRSF13B is a potential contributor to prostate cancer. Cancer Cell International. 22: 180 |
| Yeh HC, Su CC, Wu YH, et al. (2022) Novel insights into the anti-cancer effects of 3-bromopyruvic acid against castration-resistant prostate cancer. European Journal of Pharmacology. 174929 |
| Chang HH, Lee CH, Chen YT, et al. (2022) Genetic Analysis Reveals the Prognostic Significance of the DNA Mismatch Repair Gene in Advanced Prostate Cancer. Cancers. 14 |
| Karunasinghe N, Minas TZ, Bao BY, et al. (2022) Assessment of factors associated with PSA level in prostate cancer cases and controls from three geographical regions. Scientific Reports. 12: 55 |
| Wang SH, Huang SP, Pan YJ, et al. (2021) Association between the polygenic liabilities for prostate cancer and breast cancer with biochemical recurrence after radical prostatectomy for localized prostate cancer. American Journal of Cancer Research. 11: 2331-2342 |
| Huang SP, Chen YT, Chen LC, et al. (2021) Genetic Variant Influences the Efficacy of Androgen-Deprivation Therapy in Men with Prostate Cancer. Biomedicines. 9 |
| Huang SP, Chen LC, Chen YT, et al. (2021) Genetic Variants Affect the Clinical Response to Androgen-deprivation Therapy in Patients With Prostate Cancer. Cancer Genomics & Proteomics. 18: 325-334 |